Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.

Guru Sonpavde, Juliane Manitz, Chen Gao, Darren Tayama, Constanze Kaiser, Daniel Hennessy, Doris Makari, Ashok Gupta, Shaad Essa Abdullah, Guenter Niegisch, Jonathan E. Rosenberg, Dean F. Bajorin, Petros Grivas, Andrea B. Apolo, Robert Dreicer, Noah M. Hahn, Matthew D. Galsky, Andrea Necchi, Sandy Srinivas, Thomas PowlesToni K. Choueiri, Gregory R. Pond

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.'. Together they form a unique fingerprint.

Medicine & Life Sciences